UPDATED Mar 15, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
LQWC | US$0.016 | -11.1% | -20.0% | US$1.9m | n/a | PS13.3x | n/a | n/a | ||
ELF | US$199.37 | -0.8% | 175.1% | US$11.1b | US$207.08 | PE85.5x | E30.7% | n/a | ||
MED | US$36.61 | -7.7% | -64.4% | US$372.7m | US$37.50 | PE4x | E-63.2% | 0% | ||
GHSI | US$8.12 | 2.1% | 68.1% | US$10.4m | n/a | PB1.3x | E46.7% | n/a | ||
INBP | US$0.22 | -4.8% | -44.0% | US$6.6m | n/a | PB0.4x | n/a | n/a | ||
ODD | US$44.43 | -1.0% | n/a | US$2.6b | US$52.83 | PE43.2x | E21.3% | n/a | ||
SLGD | US$0.80 | 2.6% | 223.2% | US$10.3m | n/a | PB1.8x | n/a | n/a | ||
HNST | US$4.30 | -2.7% | 147.1% | US$436.3m | US$4.69 | PS1.2x | E63.3% | n/a | ||
CVSI | US$0.034 | 1.6% | -11.6% | US$5.6m | n/a | PE7.5x | n/a | n/a | ||
DQWS | US$0.05 | 0% | -50.1% | US$10.3m | n/a | PS8.1x | n/a | n/a | ||
LIFD | US$2.89 | 0% | -27.8% | US$42.8m | n/a | PE15.6x | n/a | n/a | ||
UG | US$7.74 | -5.7% | -14.6% | US$34.8m | n/a | PE14.1x | n/a | 2.6% | ||
NATR | US$20.11 | 12.7% | 94.9% | US$369.2m | US$24.00 | PE25.1x | E10.8% | 0% | ||
NHTC | US$6.59 | 5.9% | 29.7% | US$72.7m | n/a | PE132.9x | n/a | 12.1% | ||
WDFC | US$249.91 | -1.2% | 45.4% | US$3.4b | US$281.50 | PE49x | E10.1% | 1.4% | ||
LFVN | US$7.00 | 0.8% | 105.9% | US$88.7m | n/a | PE30.4x | S4.0% | 2.0% | ||
SPB | US$83.18 | -0.4% | 42.1% | US$2.9b | US$92.88 | PS1x | E48.0% | 2.0% | ||
VERU | US$0.58 | -10.4% | -63.7% | US$87.8m | US$4.50 | PS5.2x | E67.7% | 0% | ||
ODC | US$70.69 | -0.6% | 87.4% | US$510.1m | n/a | PE12.5x | n/a | 1.6% | ||
THRN | US$10.19 | 0.1% | 128.5% | US$550.6m | US$8.60 | PE27.1x | E57.2% | n/a | ||
FTLF | US$21.75 | -0.05% | 24.3% | US$100.5m | n/a | PE23.3x | n/a | n/a | ||
AXIL | US$12.50 | -1.6% | 79.2% | US$72.9m | n/a | PE34.9x | n/a | n/a | ||
IPAR | US$135.32 | -2.6% | -1.2% | US$4.3b | US$170.63 | PE28.4x | E9.1% | 2.2% | ||
NUS | US$13.25 | 4.0% | -65.3% | US$634.1m | US$15.50 | PE76.2x | E74.1% | 1.8% |